Bilaketaren emaitzak - Willeke M. C. van Roon‐Mom

Findu emaitzak
  1. 1
    Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders

    Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders nork Marlen C. Lauffer, Willeke M. C. van Roon‐Mom, Annemieke Aartsma‐Rus

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Antisense oligonucleotides in therapy for neurodegenerative disorders

    Antisense oligonucleotides in therapy for neurodegenerative disorders nork Melvin M. Evers, Lodewijk J.A. Toonen, Willeke M. C. van Roon‐Mom

    Argitaratua 2015
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies

    Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies nork Melvin M. Evers, Lodewijk J.A. Toonen, Willeke M. C. van Roon‐Mom

    Argitaratua 2013
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice

    Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice nork Lodewijk J.A. Toonen, Frank Rigo, Haico van Attikum, Willeke M. C. van Roon‐Mom

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review

    Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review nork Hannah S. Bakels, Raymund A.C. Roos, Willeke M. C. van Roon‐Mom, Susanne T. de Bot

    Argitaratua 2021
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias

    Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias nork Ronald A.M. Buijsen, Lodewijk J.A. Toonen, Sarah L. Gardiner, Willeke M. C. van Roon‐Mom

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex

    Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex nork Tamara Maiuri, Andrew J. Mocle, Claudia Lin-Kar Hung, Jianrun Xia, Willeke M. C. van Roon‐Mom, Ray Truant

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease

    Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease nork Boyd Kenkhuis, Antonios Somarakis, Lynn R.T. Kleindouwel, Willeke M. C. van Roon‐Mom, Thomas Höllt, Louise van der Weerd

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA

    Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA nork Anastasios Mastrokolias, Johan T. den Dunnen, Gert‐Jan B. van Ommen, Peter A.C. ‘t Hoen, Willeke M. C. van Roon‐Mom

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues

    Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues nork Alexander E. Ivliev, Peter A.C. ‘t Hoen, Willeke M. C. van Roon‐Mom, Dorien J.M. Peters, Marina G. Sergeeva

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives

    Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives nork Matthis Synofzik, Willeke M. C. van Roon‐Mom, Georg Marckmann, Hermine A. van Duyvenvoorde, Holm Graeßner, Rebecca Schüle, Annemieke Aartsma‐Rus

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides

    Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides nork Aurélie Goyenvalle, C. Jimenez‐Mallebrera, Willeke M. C. van Roon‐Mom, Sabine Sewing, Arthur Μ. Krieg, Virginia Arechavala‐Gomeza, Patrik Andersson

    Argitaratua 2022
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia

    Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia nork Boyd Kenkhuis, Michelle van Eekeren, David A. Parfitt, Yavuz Ariyürek, Poulomi Banerjee, Josef Priller, Louise van der Weerd, Willeke M. C. van Roon‐Mom

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6/2 mice

    Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6/2 mice nork Max Gentenaar, Fleur L. Meulmeester, Ximaine van der Burg, Anna T. Hoekstra, Hazel Hunt, Jan Kroon, Willeke M. C. van Roon‐Mom, Onno C. Meijer

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain

    Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain nork Maurice A. Curtis, Ellen B. Penney, Andree G. Pearson, Willeke M. C. van Roon‐Mom, N.J Butterworth, Michael Dragunow, Bronwen Connor, Richard L. M. Faull

    Argitaratua 2003
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides

    Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides nork Annemieke Aartsma‐Rus, Alejandro Garanto, Willeke M. C. van Roon‐Mom, Erin M. McConnell, Victoria Suslovitch, Winston X. Yan, Jonathan K. Watts, Timothy W. Yu

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Striosomes and mood dysfunction in Huntington's disease

    Striosomes and mood dysfunction in Huntington's disease nork Lynette J. Tippett, Henry J. Waldvogel, Sally Thomas, Virginia M. Hogg, Willeke M. C. van Roon‐Mom, Beth J. Synek, Ann M. Graybiel, Richard L. M. Faull

    Argitaratua 2006
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification

    Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification nork Melvin M. Evers, Hoang-Dai Tran, Ioannis Zalachoras, Onno C. Meijer, Johan T. den Dunnen, Gert‐Jan B. van Ommen, Annemieke Aartsma‐Rus, Willeke M. C. van Roon‐Mom

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations

    Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations nork Annemieke Aartsma‐Rus, Willeke M. C. van Roon‐Mom, Marlen C. Lauffer, Christine L. E. Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle, Matthis Synofzik, Holm Graeßner

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide

    Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide nork Melvin M. Evers, Barry A. Pepers, J.C.T. van Deutekom, Susan Mulders, Johan T. den Dunnen, Annemieke Aartsma‐Rus, Gert‐Jan B. van Ommen, Willeke M. C. van Roon‐Mom

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: